Specific reagent dedicated to viral applications demonstrates an exceptionally high efficiency to promote, control and assist viral transductions
Oz Biosciences announces the launch of a new Magnetofection based product, dedicated to viral applications.
Issued from Magnetofection technology, ViroMag is a specific formulation designed to be used in association with all viral vectors and for many transduction applications.
For the first time, scientists will be able to increase transduction efficiency, infect non permissive cells, concentrate virus onto cells or in culture medium, or synchronise infection without modification of the viruses, just by associating ViroMag reagent to the viral vectors.
ViroMag is said to be the only reagent available offering a solution to such applications.
ViroMag is a unique and specific reagent dedicated to all viral applications.
This reagent demonstrates an exceptionally high efficiency to promote, control and assist viral transductions.
The conducted studies have shown that ViroMag increases transduction efficiency, concentrates viral dose, promotes and accelerates the infection process, improves viral infectious capacity, extends the host tropisms of viral vectors to non-permissive cells, allows the synchronisation of the transduction and can provide a magnetic targeting.
Magnetofection is an innovative, simple and highly efficient viral and non-viral gene delivery method.
It exploits magnetic force exerted upon gene vectors associated with magnetic particles to drive the nucleic acids or virus towards, possibly even into, the target cells.
In this manner, the complete applied nucleic acid and viral dose gets concentrated on the cells within a few minutes so that 100% of the cells get in contact with a significant vector dose.
Commercialised since 2003 by Oz Biosciences, Magnetofection has, it says, become the preferred method of various research laboratories in the world for their transfection experiments with numerous nucleic acids and cell types.
